chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse events at time of  injections. Became ill 4 months after receiving 2nd vaccine. Undiagnosed illness after many blood tests and chest xrays. Had fever, body aches, chills and headache for 15 days. After 15 days, symptoms disappeared on their own without medications other than advil/tylenol.
Blurry vision; Rash below the vaccination site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision), RASH (Rash below the vaccination site) and HEADACHE (Headache) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced VISION BLURRED (Blurry vision), RASH (Rash below the vaccination site) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, VISION BLURRED (Blurry vision), RASH (Rash below the vaccination site) and HEADACHE (Headache) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.  No relevant concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Additional information received on 09-Apr-2021 : Reporter contact details updated, additional events( headache, blurred vision) added
Information has been received from a physician concerning an approximately 12 years old female who was vaccinated with a 0.5ml dose of VARIVAX (Merck) (lot#, route and site of administration not reported) as a baby. In spring 2009, the patient developed chickenpox. Unspecified medical attention was sought. No lab diagnostics studies performed. On an unspecified date the patient recovered. No further information is available.
PATIENT RECEIVED THE ABOVE VACCINATIONS, AS WELL AS A BICILLIN INJECTION. WITHIN 10 MINUTES THE LAST INJECTION (BICILLIN), THE PATIENT'S LOWER LIP BEGAN TO SWELL.
Initial information received on 06-Nov-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2018SA312352 and 2018SA308949 (same reporter). This case involves adult female patient (nurse) (age not reported) who was vaccinated with a 0.5 ml dose of FLUZONE QUADRIVALENT (Batch number: UT6258MA and expiry date: 30-Jun-2019, dose in series, route and site of administration were not reported) on an unknown date. The patient's past medical history, medical treatment(s), vaccination(s), family history and concomitant medications were not provided. It was a case of Occupational exposure to product because the nurse pushed the thing up and then felt wetness on my hand. No Lab data was reported. It was unknown whether the patient received any corrective treatment or not. Documents held by the sender: none.
Vaccine was not administered d/t error drawing up vaccine from vial.  Needle was pushed through vaccine into air space of vial and injected into patient. No injuries reported from vaccine recipient and have been rescheduled to receive their vaccine.
localized swelling, redness, and itching at injection site (2inches x 2 inches) 10 days post injection.
Soreness around injection site with cold sensations coming and going in that area.  Next day: medium red rash around site; 1"x1-1/2"; off/on cold sensation continue all day; rash a deep red at end of day.  Third day: rash larger on waking - 1-3/4"x1-1/2". By evening swollen and larger 1-1/2"x2-1/4".  Fourth day: size remained the same; color began to fade around the edges but still deep red in center core; still swollen.  Fifth day: reduced in size by about 1/3; color now medium pink over all; swelling same.  Sixth day: swelling gone, mottled medium & light pink, slightly smaller.  Continued to gradually fade away over the next week.  Cold sensations came and went throughout the entire time.
Sinus; This is a spontaneous report from Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient said she had sinus and went to her primary doctor and provided her steroids. The patient was scheduled to get the second dose this coming Sunday. The patient wants to know if she can take the second dose. Therapeutic measures were taken as a result of sinus included steroids (unspecified). The outcome of the event was unknown.  Information on lot/batch number has been requested.
Pt developed a headache, stomach upset/nausea, arm swelling around injection site, arm was red and hot and sore. Her hand felt cold to the touch and she lost feeling in her pinky and ring finger.  Reactions developed the evening of the shot and worsened over 24 hours, then begin to slowly improve. Patient did not seek medical attention for the reaction.
swelling at injection site; pain at injection site; Warm to touch; swelling and pain at injection site and then progression to formation of tense bullae and erythema and induration; swelling and pain at injection site and then progression to formation of tense bullae and erythema and induration; swelling and pain at injection site and then progression to formation of tense bullae and erythema and induration; This is a spontaneous report from a contactable physician. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular route, administered in left deltoid on 03Mar2021 (Batch/Lot Number: EN6205 6130121) as dose 1, single for COVID-19 immunisation. The patient's medical history included COVID-19 and concomitant medications were not reported. The patient did not receive any vaccine within 4 weeks of the vaccination. The patient was not tested for COVID post vaccination. On 04Mar2021, about 6-8 hours prior to arrival in ED (Emergency department) the patient started to have swelling and pain at injection site and then it was progressed to formation of tense bullae and erythema and induration. It was warm to the touch and painful. As corrective measure clindamycin, hydrocortisone cream was taken by the patient. The outcome was unknown for the reported events.  No follow-up attempts are possible. No further information is expected.
Sarcoidosis of heart, Sudden heart damage and Heart Failure. Died in his sleep on August 2nd.
Local reaction @ injection site left deltoid. Redness and swelling 45mm. Tender to touch. Pt c/o pain/discomfort. Nasal congestion, fever and dry cough x 3 days.
Almost inmediately after administration of GARDASIL9, the patient had a syncope episode; Patient fell foward; Patient knockedout a front tooth; This spontaneous case was received from a nurse, concerning a 12 years old male patient. The patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications were unknown by reporter.  On 26-JUN-2019, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), 1 dosage form, per intramuscular route, (strength,  lot number and expiration date were unknown by reporter) for prevent human papilloma virus (HPV). On the same date, the patient also was vaccinated with a dose of meningococcal ACYW conj vaccine (CRM197) (MENVEO) (, (strength, dose, frequency, route of administration, lot number, expiration date and indication were not reported).   On the same date,  almost immediately after the administration of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), the patient experienced syncope episode, fell forward (fall) and knocked out a front tooth (tooth avulsion).It was reported that the patient sought medical attention; but it was unknown by reporter if any laboratory diagnostic or studies were performed or if the patient received any treatment for the events.  In approximately June 2019, the patient's tooth was recovered, and the patient visited an unspecified dentist and the tooth was placed back in the mouth.  At the reporting time the outcome of the syncope episode and fall, , and the causality assessment between HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) administration and all the events occurrence were not provided.
Pt. called the evening of his shot given earlier that day reporting arm at injection site very red & swollen.
suicidual thoughts, hospitalized many times for psychosis, catatonia, Schizophrenia.  prior to vaccine I was a functional adult working full time, college and now I can only work part time (with father)
PT REPORTED CHEST PAIN AT 2AM THAT NIGHT AFTER HER VACCINE WHICH LASTED ABOUT 5 MINUTES. SHE ALSO HAD HEADACHE THE FOLLOWING MORNING.
Chills, fever, headache, fatigue, arm pain, nausea, weakness, body aches ...my daily check in would not work, I called CDC customer report and they told me to list my symptoms here on this form.
She noticed that she got breakthrough bleeding, when she just got her menstruation last week; This is a spontaneous report from a contactable healthcare professional, the patient.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 16Dec2020 at 17:00 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  On an unknown date in Dec2020, the patient noticed that she had breakthrough bleeding and she just had her period last week. The stated that she was very regular when it came to her period. The clinical outcome of the breakthrough bleeding was unknown.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Pt. was vaccinated in pharmacy clinic at 3:00pm. At home on same day at 8:00pm pt. began convulsing, body cramps, flu-like SXS, SOB that lasted 18-20 hrs. Pt. has a caregiver with him. Major ice storm was happening so he did not seek medical attention. SXS went away in 18-20 hrs as quick as onset. Pt. ate, rehydrated. Pt. broke out mild with shingles outbreak previously.
This spontaneous report was received from a Certified Medical Assistant concerning multiple unspecified patients (demographics unknown). On an unknown date the multiple patients were vaccinated with VARIVAX (Merck) (lot #, dose and route were not provided). The VARIVAX (Merck) was administered post supported excursion. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Mouth irritation; blood blister on the inside of my mouth; This is a spontaneous report from a contactable Consumer. This 65-year-old female Consumer (patient) reported for self via medical information team.  A 65-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: EN6199, Expiry date: unknown) via an unspecified route of administration, administered in left arm on 03Mar2021 (65-year-old at the time of vaccination) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication(s) included levothyroxine (LEVOTHYROXINE) 100 mg once a day taken for an unspecified indication, and atorvastatin (ATORVASTATIN) 40 mg once a day taken for an unspecified indication. The patient previously took first dose of bnt162b2(PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Batch/lot number: EN6201, Expiry date: unknown) via an unspecified route of administration, on 10Feb2021 (age at vaccination: 65-years-old) as dose 1, single for COVID-19 immunization. It was reported that on an unspecified date in Mar2021, three weeks after the second dose patient developed a blood blister inside her mouth and mouth irritation. that she had the first dose of the Pfizer covid 19 vaccine on 10Feb2021 and the second dose on 3Mar2021. Reporter reported that three weeks after the second dose she developed a blood blister inside her mouth. reporter asked if other people have reported this and how long is it likely to last. she is going to her dentist. Reporter stated she saw a study on line that is looking at 1580 HCP who experienced mouth ulcers and blisters but she did not know which vaccine. weeks of the second vaccine, I started experiencing some mouth irritations, primarily the one I that am really the most concerned about is like a blood blister on the inside of my mouth and again it was like the 3rd week of Mar or so and it still has not gone away. I have an appointment with my dentist tomorrow, but I thought I should talk to you first and see if there are other people reporting this and you know what you think about it what I should tell the dentist potentially what I felt." Patient stated she was going to her dentist and no treatment has been taken for the events. The patient said she will go to the dentist tomorrow, if I could find out if there is any probable correlation between the vaccine you know blisters in my mouth." The patient not received any treatment for events. The outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.
This case was considered medically important. Information regarding Hib-Titer Vaccine was received from a father of a male patient who received the fifth dose on either 17-Dec-2002 or 15-Jan-2003 and experienced autism. On 17-Dec-2002 or 15-Jan-2003, the patient received the fifth dose of Hib-Titer. In early 2003, the child was diagnosed with autism. The patient had not recovered from the event. No additional information was available at the time of this report.
Headache, Myalgia, injection site pain with both doses, other symptoms with second dose for 48 hrs
patient passed out 2 minutes after vaccine ,called 911 and the er doctor said it was syncope
Fever developed about 8.5 hours later, per parent report. Fever lasted for ~ 5 days after vaccine was given. Cough developed on day 4 of fever. No other symptoms.
Shingles rash left side of face...at time of reporting: one week post vaccination, rash continues.
lethargic; trouble breathing; fever; Sore arm at injection site; tiredness; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received bnt162b2 (Pfizer COVID 19 ), dose 1 via an unspecified route of administration, administered in left arm on 12Apr2021 11:15 (Lot Number: EW0158) as dose 1, single at the age of 61-year-old for COVID-19 immunisation. The patient was not pregnant. Medical history included renal hypertension, osteoarthritis, born with one kidney, shellfish allergy, insulin allergy. Concomitant medications included pravastatin; candesartan cilexetil; chlorthalidone, all taken for an unspecified indication in two weeks. No other vaccine in four weeks. The patient experienced sore arm at injection site, tiredness on 15Apr2021. About a week later she was lethargic and had a fever, trouble breathing. Had to call ambulance to be transported to the hospital and was admitted. AE resulted in emergency room/department, hospitalization for 9 days, life threatening illness (immediate risk of death from the event). Treatment received for the events which included oxygen, medication. No COVID prior vaccination. It was unknown If COVID tested post vaccination. The outcome of events was recovering.
Client states that she received vaccine on Thursday 6-2-16.  (Records show it was actually done on 5-31-16)  Client states that her arm was swollen and reddened but she went to work that evening and was able to work okay.  Client states Friday night, Saturday morning around 2:30am she started to have abdominal pain and vomiting and diarrhea.  Client states that she went to ER Saturday afternoon 6-4-16 and was given IV Zofran and amlodipine because her B/P was high.  Client states at the time her arm was just tight.  Client states that vomiting and diarrhea was less on Sunday.  Client states on Monday she was still vomiting and was weak and her B/P was going up and done so she went back to the ER.  Client states that she was given Norvasc and Tylenol and sent home and referred for follow up with her cardiologist.  Filed per client's request.
Pt developed rash on back. This was her second dose. She feels it is getting better. She states it is not itching.  I advised her to call her physician as well.
This case was reported by a physician and described the occurrence of hepatitis B surface antigen positive in a 60-year-old male subject who was vaccinated with Engerix B (GlaxoSmithKline) for prophylaxis.  Concurrent medical conditions included elevated prostate specific antigen, hemodialysis, IgE nephropathy, radiocarativity in one eye and proteinuria.  Concurrent medications included Epogen, Zemplar, Calcitrol, Diovan, Flomax, Fosamax, Lipitor, Niacin, prednisone, terazosin and Tramadol.  On 18 June 2007 the subject received 1st dose of Engerix B at 40 mcg.  The subject had been tested that same day and was found to be hepatitis B surface antigen negative.  On 21 June 2007, the subject was tested again and was found to be hepatitis B surface antigen positive.  At the time of reporting the outcome of the event was unspecified.  Follow-up information was received from the reporting physician on 06 July 2007.  The reporting physician considered the event of hepatitis B surface antigen positive to be related to Engerix B.  He considered the event was not serious.
Initially got fever symptoms about 9 hours after shot. At 3:00 am I started getting strong headaches and chest pains that next morning and they have come and gone since. 12/28/2021 at 1:00 pm I got an extremely aggressive sharp pain in my left side of chest and when I breath it hurts even more.
12/29/2020 Vaccination. Within minutes blurry vision, dizzy, tx to stretcher. EXTREME HA, coughing, sensitivity to light. EPI pen in ER. I fell asleep. Woke up, don't remember much. Admitted to hospital. Chest pains started within 2 hours, SOB, HA. Admitted for 2 nights, 3 days. Discharged home. Still having SOB and referred to Pulmonologist. Waiting on appt.  *did NOT have problems before this vaccine.  I was fine. Now i am completely different person, I have to monitor my walking, etc.
Crying, Low grade fever, redness at site of injection. Received Tylenol.
Case developed rash at injection site 4 days after second vaccine. Rash became systemic. Case reports after seeking care from PCP and dermatologist he was diagnosed with pityriasis rubra pilaris.
Injection site turned red & achy, an inch or two across;  over next four days, red spot grew to a 3?x6? blotch and so painful patient took Tylenol.
Extra alert all night, difficulty sleeping, felt like I had caffeine buzz in my digestive track. Work next morning with abdominal pain, stiffness. Hungry but didn't feel like eating cuz of pain. Not nausea. Abdominal pain felt more upon standing and walking and eased when reclining, bloated feeling too.
(Left arm; varicella) red circle about 1 inch across within hours. It grew to 3 inches across overnight and by 24 hours later, small white blisters formed near injection site. Merged into one 2 inch across blister by evening, when we took her to urgent care with a 100.8 F fever. They said to give her ibuprofen, Zyrtec, cold compresses and to apply neosporin after blister burst. Blister broke that night after growing to half inch thick. Late second morning, more blisters appeared and grew to a one inch size next to burst first one, saw doctor at peds clinic Thursday afternoon about 48 hours after shot; he prescribed prednisone, Zyrtec liquid, and Keflex, which we started last night. Told us to outline the extent of outer red, warm ring (it now covers 90% of upper arm). Have another appt today with same peds doctor to assess if it's still getting worse.
After receiving IZ, family noted that patient was splotchy and covered with a rash on face and neck. RN and MA obtained vitals and MD was notified immediately. Vitals stable, red splotchy rash gradually vanished.
Fours days post vax, this pt experienced pain at the injection site which radiated to her shoulder, back, and neck. She also experienced weakness and heaviness in her arm, causing difficulty lifting or using the arm. She recovered in 2 days without treatment.
Low fever, Wheezing, Hoarsness, chills, aches, cough.
I experienced prickly heat to my face and neck, red splotches on my face and a racing heartbeat lasting only about ten minutes.  It began to subside and I took Benadryl 25mg about fifteen minutes later with no additional symptoms.  Nothing else was different about my morning routine but felt this was worth reporting since it may have been from the vaccine about 19 hours previously.  It felt severe at the time but began resolving before I attempted to contact medical personnel.
Burning sensation in arm. Lightheaded.  Dizzy. Nausea. Severe headache. Fever. Chills/Sweating. Elevated heart rate / Palpitations.
Quite sore arm, aching muscles/joints, slight nausea, general fatigue, slight dizziness
This spontaneous report as received from a registered nurse refers to a female patient of unknown age. On 19-AUG-2013 the patient was vaccinated with GARDASIL dose 2, 0.5 ml, intramuscular. The nurse reports that patient received her first dose of GARDASIL (injection, 0.5 ml, intramuscular) in July 2011 and the patient was in the office presently(19-AUG-2013) to receive her second dose of GARDASIL (injection, 0.5 ml, intramuscular). No adverse effect was reported. The outcome was unknown. Additional information has been requested.
Pt developed "tin" taste in mouth 2 hours after Adacel shot.  Rapid progression over 48h of weakness leg, foot.  Guillain Barre, hospital, respirator dependent.12/28/07-records received with report for DOS 11/23-12/19/07-DC DX: Guillain-Barre syndrome treated with plasmapheresis and IVIG. Required a tracheotomy and feeding tube placement. Three days prior to admission received tetanus shot. Two hours after shot developed tinny taste in mouth and paresthesias on tongue that reolved that day. Two days prior to admission noticed numbness and tingling on soles of both feet and his hands felt hot underneath cold water. Day prior to admission awoke and noticed bilateral leg weakness with mild left foot drop and weakness in proximal arms. Developed progressive weakness with hypophonic speech, decreased cough and neck flexion weakness. Required mechanical ventilation. 1/15/2010 Weakness arms, legs, and hands.
OFF-LABEL ADMINISTRATION OF VACCINE. INADVERTENTLY ADMINISTERED MENACTRA INSTEAD OF MENOMUNE. MENACTRA IS USED FOR PERSONS AGED 55-YEARS-OLD AND YOUNGER.
ONE INCH WIDE BY ONE-HALF INCH LONG BRUISE AROUND INJECTION SITE. 3X3 INCH RASH/RED SWELLING ON LOWER ARM THAT IS WARM TO TOUCH.
pt recv vax & 5 days post vax was dx w/acute meningitis, viral type, cerebral edema, bronchitis, diffuse, interstitial pneumonia;
6/14 Increased redness, swelling and warmth left thigh-seen in clinic. 6/14 and 6/15 seen at children's ER. 6/16 seen in clinic.
pt recvd vax;devel flu-like sxs (aches,fatigue,sl cough); a few days later,devel a rash described as "measle-like" which was diff from the previous rash;
Rash appeared about 8 days after receiving shot on the arm at the injection site. Lasted for about one week. Hot to touch, itchy, skin scaly in texture.  About 3 weeks after the first dose shot, developed prominent breast lumps in both breasts that were not present previously. Most prominent lump in the 11 o clock position near center of breast.   About 3 weeks after the first dose developed a rash on both breasts at the same time as breast lumps. After one week rash covered about 80% of the body, red itchy blotches.